Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oglemilast in the Prevention of Allergen-induced Bronchospasm

NCT00322686 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00322686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oglemilast in the Prevention of Allergen-induced Bronchospasm
Lead sponsor
Forest Laboratories
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
Not reported
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma